Hopper JL - Search Results

1

Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.

MacInnis RJ, Pike MC, Hopper JL. MacInnis RJ, et al. Among authors: hopper jl. N Engl J Med. 2016 Jun 16;374(24):2403-4. doi: 10.1056/NEJMc1602861. N Engl J Med. 2016. PMID: 27305206 No abstract available.

2

Risk factors and preventive strategies for breast cancer.

McCredie M, Hopper JL, Cawson JN. McCredie M, et al. Among authors: hopper jl. Med J Aust. 1995 Oct 16;163(8):435-40. Med J Aust. 1995. PMID: 7476618

3

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer.

Spurdle AB, Goodwin B, Hodgson E, Hopper JL, Chen X, Purdie DM, McCredie MR, Giles GG, Chenevix-Trench G, Liddle C. Spurdle AB, et al. Among authors: hopper jl. Pharmacogenetics. 2002 Jul;12(5):355-66. doi: 10.1097/00008571-200207000-00003. Pharmacogenetics. 2002. PMID: 12142725

4

Heritability of mammographic density, a risk factor for breast cancer.

Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL. Boyd NF, et al. Among authors: hopper jl. N Engl J Med. 2002 Sep 19;347(12):886-94. doi: 10.1056/NEJMoa013390. N Engl J Med. 2002. PMID: 12239257

5

Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women.

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G. Spurdle AB, et al. Among authors: hopper jl. Lancet. 2002 Sep 21;360(9337):925-6. doi: 10.1016/S0140-6736(02)11043-9. Lancet. 2002. PMID: 12354477

6

Early growth, adult body size and prostate cancer risk.

Giles GG, Severi G, English DR, McCredie MR, MacInnis R, Boyle P, Hopper JL. Giles GG, et al. Among authors: hopper jl. Int J Cancer. 2003 Jan 10;103(2):241-5. doi: 10.1002/ijc.10810. Int J Cancer. 2003. PMID: 12455039

7

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics.

Scott CL, Jenkins MA, Southey MC, Davis TA, Leary JA, Easton DF, Phillips KA, Hopper JL. Scott CL, et al. Among authors: hopper jl. Hum Genet. 2003 May;112(5-6):542-51. doi: 10.1007/s00439-003-0908-6. Epub 2003 Feb 25. Hum Genet. 2003. PMID: 12601471

8

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL. Dite GS, et al. Among authors: hopper jl. J Natl Cancer Inst. 2003 Mar 19;95(6):448-57. doi: 10.1093/jnci/95.6.448. J Natl Cancer Inst. 2003. PMID: 12644538

9

The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.

Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. Montgomery KG, et al. Among authors: hopper jl. Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1109-11. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14578152

10

Body size and composition and prostate cancer risk.

MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. MacInnis RJ, et al. Among authors: hopper jl. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1417-21. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results